Protalix BioTherapeutics Inc
(FRA:PBDA)
€
2
+0.042 (+2.15%)
Market Cap: 162.78 Mil
Enterprise Value: 135.63 Mil
PE Ratio: 10.17
PB Ratio: 2.64
GF Score: 56/100 Protalix BioTherapeutics Inc (FRA:PBDA) Transcripts
- 1